Invesaro

Stocks Comparison

Alcon vs Staar Surgical: revenue, profit, margins and growth compared

Alcon brought in $10.4B of revenue in fiscal 2025, Staar Surgical $239.4M in fiscal 2025. Revenue changed by +4.9% at Alcon and -23.7% at Staar Surgical on the year before, so Alcon grew faster. Alcon kept 9.4% of its revenue as net profit, Staar Surgical -33.6%. Free cash flow was $1.7B at Alcon and -$40.1M at Staar Surgical.

Side by side, latest fiscal year

ALCSTAA
Fiscal year endedFY2025 (December 31, 2025)FY2025 (January 2, 2026)
Revenue$10.4B$239.4M
Revenue growth+4.9%-23.7%
Net income$980M-$80.4M
Net margin9.4%-33.6%
Free cash flow$1.7B-$40.1M
Free cash flow margin16.6%-16.7%
Earnings per share (diluted)$1.98-$1.62
Cash$1.5B$153.2M
Debt$4.7Bn/a
Price to earningsn/an/a
Market value$32.2B$1B
Dividend yieldn/an/a
Rank by revenue in sector#44 of 523 · Health care#239 of 523 · Health care

Over the years

Revenue
ALC FY2019: $7.2BALC FY2019: $7.5BALC FY2020: $6.8BALC FY2021: $8.3BALC FY2022: $8.7BALC FY2023: $9.5BALC FY2024: $9.9BALC FY2025: $10.4BSTAA FY2018: $124MSTAA FY2019: $150.2MSTAA FY2020: $163.5MSTAA FY2021: $230.5MSTAA FY2022: $239.4MSTAA FY2023: $322.4MSTAA FY2024: $313.9MSTAA FY2025: $239.4MFY18FY19FY20FY21FY22FY23FY24FY25
ALC $10.4BSTAA $239.4M
Net income
ALC FY2019: -$227MALC FY2019: -$656MALC FY2020: -$531MALC FY2021: $376MALC FY2022: $335MALC FY2023: $974MALC FY2024: $1BALC FY2025: $980MSTAA FY2018: $5MSTAA FY2019: $14MSTAA FY2020: $5.9MSTAA FY2021: $27.5MSTAA FY2022: $39.7MSTAA FY2023: $21.3MSTAA FY2024: -$20.2MSTAA FY2025: -$80.4MFY18FY19FY20FY21FY22FY23FY24FY25
ALC $980MSTAA -$80.4M
Net margin
ALC FY2019: -3.2%ALC FY2019: -8.7%ALC FY2020: -7.8%ALC FY2021: 4.5%ALC FY2022: 3.8%ALC FY2023: 10.3%ALC FY2024: 10.3%ALC FY2025: 9.4%STAA FY2018: 4.0%STAA FY2019: 9.4%STAA FY2020: 3.6%STAA FY2021: 11.9%STAA FY2022: 16.6%STAA FY2023: 6.6%STAA FY2024: -6.4%STAA FY2025: -33.6%FY18FY19FY20FY21FY22FY23FY24FY25
ALC 9.4%STAA -33.6%
Revenue growth
ALC FY2019: +5.0%ALC FY2020: -9.0%ALC FY2021: +21.3%ALC FY2022: +5.1%ALC FY2023: +8.5%ALC FY2024: +4.8%ALC FY2025: +4.9%STAA FY2019: +21.2%STAA FY2020: +8.8%STAA FY2021: +41.0%STAA FY2022: +3.9%STAA FY2023: +34.7%STAA FY2024: -2.6%STAA FY2025: -23.7%FY19FY20FY21FY22FY23FY24FY25
ALC +4.9%STAA -23.7%
Free cash flow
ALC FY2019: $616MALC FY2019: $367MALC FY2020: $344MALC FY2021: $645MALC FY2022: $581MALC FY2023: $730MALC FY2024: $1.6BALC FY2025: $1.7BSTAA FY2018: $10.5MSTAA FY2019: $15.7MSTAA FY2020: $12.5MSTAA FY2021: $30.3MSTAA FY2022: $17.6MSTAA FY2023: -$3.6MSTAA FY2024: -$7.7MSTAA FY2025: -$40.1MFY18FY19FY20FY21FY22FY23FY24FY25
ALC $1.7BSTAA -$40.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about Alcon and Staar Surgical

Which is bigger by revenue, Alcon or Staar Surgical?

Alcon is bigger by revenue: $10.4B in fiscal 2025, against $239.4M for Staar Surgical in fiscal 2025.

Which keeps more of its revenue as profit, Alcon or Staar Surgical?

Alcon had a net margin of 9.4% in fiscal 2025; Staar Surgical had -33.6% in fiscal 2025.

Which grew revenue faster, Alcon or Staar Surgical?

In their latest fiscal years revenue changed by +4.9% at Alcon and -23.7% at Staar Surgical.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies